Patti, here is some uncontrolled patient experience: The patient (me) was diagnosed in August 2003 with aggressive progressive MS. I tested negative for Lyme disease and not diagnostically positive for CPn. I guess I probably had MS but I have spent plenty of time in lyme endemic areas, so who knows.All in all, I don't at all mean to say rationale is not important. Its very important. But its only one guide, an imperfect one, and patient experience is the other guide, and you have to sorta synthesize it all. Patient experience is more applicable, but less controlled. Conclusions made from uncontrolled patient data are more likely to be relevant to your treatment aims, but they are also more likely to be mistaken conclusions in which the action of an uncontrolled variable is producing some sort of illusion or artifact.
However, I was married to a clinical microbiologist who decided to treat me empirically. I was given the following:
Doxycycline 200mg once daily with plenty of water.
Roxithromycin 150mg twice daily.
After two months, metronidizole (Flagyl) was added, 400mg three times a day for five days every three weeks.
After six months, the doxycycline was changed to rifampicin 300mg twice a day.
After one year I was considered improved enough to go on intermittent therapy, doxy/roxy for two weeks every two months, with five days of flagyl, now tinidizole (500mg twice a day) at the end.
In addition to this I took the whole gamut of supplements advised on my husband's website:
http://www.davidwheldon.co.uk/ms-treatment.html
After six months, the doxycycline was changed to rifampicin 300mg twice a day.
After one year I was considered improved enough to go on intermittent therapy, doxy/roxy for two weeks every two months, with five days of flagyl, now tinidizole (500mg twice a day) at the end.
In that time I have gone from an EDSS rating of seven going on eight, to about 1.5.
If you are taking the above, whether he has CPn or borrelia you will hold your husband's infection in stasis, pending your doctor's decision.
Sarah